alexa Validation of SPE-HPLC determination of 1,4-benzodiazepines and metabolites in blood plasma, urine, and saliva.
Pharmaceutical Sciences

Pharmaceutical Sciences

Pharmaceutica Analytica Acta

Author(s): Uddin MN, Samanidou VF, Papadoyannis IN

Abstract Share this page

Abstract A simple, sensitive, selective, and reproducible RP-HPLC method with DAD detection at 240 nm was developed for the determination of six 1,4-benzodiazepines: bromazepam (BRZ), clonazepam (CLZ), diazepam (DZP), flunitrazepam (FNZ), lorazepam (LRZ), alprazolam (APZ); and two metabolites: alpha-hydroxyalprazolam (HALZ) and alpha-hydroxytriazolam (HTZL) in human plasma, urine, and saliva, using colchicine as internal standard, after SPE using Nexus Varian cartridges. Separation was performed on a Kromasil C(8) (250 mm x 5 mm, 5 microm) analytical column with a gradient mobile phase containing methanol, ACN and 0.05 M ammonium acetate. Linearity was held within the range 0.3-20.0 ng/microL, with coefficients of determination (r(2)) better than 0.997. The within- and between-day assay RSD at 2, 4, 8 ng/microL ranged from 0.03 to 4.7\% and 0.5 to 7.0\%, respectively in standards, from 1.3 to 7.9\% and 3.3 to 7.3\%, respectively in plasma, from 2.1 to 6.0\% and 2.1 to 7.8\%, respectively in urine and at 0.5, 1.0, 2.0 ng/microL ranged from 2.22 to 5.8\% and 2.2 to 8.1\%, respectively, in saliva. The mean relative recoveries were 96.3-108.6, 96.0-108.2, 94.3-107.1, 97.0-107.0\% in within-day assay and 96.8-107.7, 94.6-107.6, 93.2-105.8, 96.0-108.6 in between-day assay for standard, plasma, urine, and saliva, respectively. The LOD and LOQ were 0.02-0.47 and 0.07-1.57 ng/microL, respectively. This article was published in J Sep Sci and referenced in Pharmaceutica Analytica Acta

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords